Analysis of Genetic Association of Intestinal Permeability in Healthy First-degree Relatives of Patients with Crohn's Disease.

Excessive intestinal permeability or intestinal barrier dysfunction as measured by various assays has been observed in various diseases. However, little is known about the factors contributing to altered gut permeability in these diseases. Our objective was to determine the genetic determinants of altered gut permeability as measured by the lactulose mannitol fractional excretion ratio (LacMan ratio) in 1075 healthy first-degree relatives of patients with Crohn's disease (CD). In a targeted analysis of single nucleotide polymorphisms (SNPs) located in genes associated with intestinal barrier function related or not to inflammatory bowel disease, we did not find a significant association with intestinal permeability. In an untargeted genome-wide association analysis, the top 100 associations were located in 22 genomic loci, although they were not statistically significant after correction for multiple testing (raw P values [1.8 × 10-7 - 1.4 × 10-5]. The lowest P value was obtained for rs9616637 (22q13.33, C22orf34), for which the minor allele A was associated with a decreased LacMan ratio. These results suggest that host genetic background has limited contribution toward intestinal permeability. Despite this, our study is currently the largest of its kind assessing gut permeability in vivo. It remains possible that smaller genetic effect sizes on LacMan ratio are not detectable in this sized cohort. Larger studies are warranted to identify the potential genetic contribution to intestinal permeability.

[1]  E. Seidman,et al.  Pancreatic Enzyme Supplementation in Patients with Atopic Dermatitis and Food Allergies: An Open-Label Pilot Study , 2018, Pediatric Drugs.

[2]  Benjamin Geiger,et al.  Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection , 2018, Science.

[3]  M. Daly,et al.  C1orf106 is a colitis risk gene that regulates stability of epithelial adherens junctions , 2018, Science.

[4]  V. Young,et al.  Real-time Measurement of Epithelial Barrier Permeability in Human Intestinal Organoids , 2017, Journal of visualized experiments : JoVE.

[5]  P. Rutgeerts,et al.  Genetic and Transcriptomic Bases of Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel Disease , 2017, Inflammatory bowel diseases.

[6]  S. Vermeire,et al.  The intestinal barrier: a fundamental role in health and disease , 2017, Expert review of gastroenterology & hepatology.

[7]  M. Surette,et al.  Age-Associated Microbial Dysbiosis Promotes Intestinal Permeability, Systemic Inflammation, and Macrophage Dysfunction , 2017, Cell host & microbe.

[8]  D. Kelly,et al.  Blood–brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders , 2016, Molecular Autism.

[9]  William J. Astle,et al.  Allelic Landscape of Human Blood Cell Trait Variation and Links , 2016 .

[10]  Moses Rodriguez,et al.  Multiple Sclerosis, Gut Microbiota and Permeability: Role of Tryptophan Catabolites, Depression and the Driving Down of Local Melatonin. , 2016, Current pharmaceutical design.

[11]  A. Paterson,et al.  Association of host genome with intestinal microbial composition in a large healthy cohort , 2016, Nature Genetics.

[12]  Alan M. Kwong,et al.  Next-generation genotype imputation service and methods , 2016, Nature Genetics.

[13]  A. Paterson,et al.  IBD Genetic Risk Profile in Healthy First-Degree Relatives of Crohn's Disease Patients. , 2016, Journal of Crohn's & colitis.

[14]  E. Mizoguchi,et al.  Genetically engineered mouse models for studying inflammatory bowel disease , 2016, The Journal of pathology.

[15]  E. Jirillo,et al.  Nutritional Keys for Intestinal Barrier Modulation , 2015, Front. Immunol..

[16]  I. Williams,et al.  Antigen sampling by intestinal M cells is the principal pathway initiating mucosal IgA production to commensal enteric bacteria , 2015, Mucosal Immunology.

[17]  Xia Li,et al.  The role for gut permeability in the pathogenesis of type 1 diabetes – a solid or leaky concept? , 2015, Pediatric diabetes.

[18]  R. D'Incà,et al.  Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut , 2015, Mediators of inflammation.

[19]  Judy H. Cho,et al.  Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations , 2015, Nature Genetics.

[20]  A. Lerner,et al.  Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease. , 2015, Autoimmunity reviews.

[21]  A. Paterson,et al.  Determinants of Intestinal Permeability in Healthy First-Degree Relatives of Individuals with Crohn's Disease , 2015, Inflammatory bowel diseases.

[22]  H. Tilg,et al.  Intestinal permeability – a new target for disease prevention and therapy , 2014, BMC Gastroenterology.

[23]  D. Mccole.  IBD Candidate Genes and Intestinal Barrier Regulation , 2014, Inflammatory bowel diseases.

[24]  Peggy Hall,et al.  The NHGRI GWAS Catalog, a curated resource of SNP-trait associations , 2013, Nucleic Acids Res..

[25]  Buhm Han,et al.  Imputing Amino Acid Polymorphisms in Human Leukocyte Antigens , 2013, PloS one.

[26]  Ellen T. Gelfand,et al.  The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.

[27]  N. Barnich,et al.  Western diet induces dysbiosis with increased E coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation , 2013, Gut.

[28]  A. Lackner,et al.  Focused Examination of the Intestinal Epithelium Reveals Transcriptional Signatures Consistent with Disturbances in Enterocyte Maturation and Differentiation during the Course of SIV Infection , 2013, PloS one.

[29]  S. Chien,et al.  Involvement of Rab28 in NF-κB Nuclear Transport in Endothelial Cells , 2013, PloS one.

[30]  T. Ochiya,et al.  Inhibition of Stabilin-2 elevates circulating hyaluronic acid levels and prevents tumor metastasis , 2012, Proceedings of the National Academy of Sciences.

[31]  Joshua M. Korn,et al.  Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease , 2011, Nature Genetics.

[32]  Y. Hata,et al.  Up-regulation of the Homophilic Adhesion Molecule Sidekick-1 in Podocytes Contributes to Glomerulosclerosis* , 2010, The Journal of Biological Chemistry.

[33]  M. Silverberg,et al.  Polymorphisms in E-cadherin (CDH1) result in a mis-localised cytoplasmic protein that is associated with Crohn’s disease , 2009, Gut.

[34]  M. Furuse.  Knockout animals and natural mutations as experimental and diagnostic tool for studying tight junction functions in vivo. , 2009, Biochimica et biophysica acta.

[35]  J. Meddings,et al.  The measurement and clinical significance of intestinal permeability , 2008, Current gastroenterology reports.

[36]  V. Srivastava,et al.  Role of Intestinal Mucins in Innate Host Defense Mechanisms against Pathogens , 2008, Journal of Innate Immunity.

[37]  Judy H. Cho,et al.  Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease , 2008, Nature Genetics.

[38]  Ali Keshavarzian,et al.  Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium. , 2008, Alcohol.

[39]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[40]  R. Paroni,et al.  Increased intestinal permeability precedes clinical onset of type 1 diabetes , 2006, Diabetologia.

[41]  M. Arrieta,et al.  Alterations in intestinal permeability , 2006, Gut.

[42]  A. Latiano,et al.  Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease , 2006, Alimentary pharmacology & therapeutics.

[43]  J. Li,et al.  Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix , 2005, Heredity.

[44]  J. Genschel,et al.  Genetic basis for increased intestinal permeability in families with Crohn’s disease: role of CARD15 3020insC mutation? , 2005, Gut.

[45]  W. Clark,et al.  Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario , 2004, Alimentary pharmacology & therapeutics.

[46]  J. Beaulieu,et al.  Proinflammatory cytokines TNF-α and IFN-γ alter laminin expression under an apoptosis-independent mechanism in human intestinal epithelial cells , 2004 .

[47]  A. Pedram,et al.  TNF-α-induced increase in intestinal epithelial tight junction permeability requires NF-κB activation , 2004 .

[48]  C. Bode,et al.  Effect of alcohol consumption on the gut. , 2003, Best practice & research. Clinical gastroenterology.

[49]  M. Feldman,et al.  Genetic Structure of Human Populations , 2002, Science.

[50]  M. Batzer,et al.  Alu repeats and human genomic diversity , 2002, Nature Reviews Genetics.

[51]  W James Gauderman,et al.  Sample size requirements for matched case‐control studies of gene–environment interaction , 2002, Statistics in medicine.

[52]  S. Walsh,et al.  Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. , 2001, The American journal of pathology.

[53]  R. Hilsden,et al.  Intestinal permeability is increased in a proportion of spouses of patients with Crohn's disease , 2001, American Journal of Gastroenterology.

[54]  F. Autschbach,et al.  Inflammatory bowel disease is associated with changes of enterocytic junctions. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[55]  C. Dupont,et al.  Intestinal permeability in children: variation with age and reliability in the diagnosis of cow's milk allergy , 2001, Acta paediatrica.

[56]  T. Noda,et al.  Complex phenotype of mice lacking occludin, a component of tight junction strands. , 2000, Molecular biology of the cell.

[57]  J. Marshall,et al.  Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk. , 2000, Gastroenterology.

[58]  P. O. Juvonen, E. M. Alhava, J. A. Takala.  Gut Permeability in Patients with Acute Pancreatitis , 2000 .

[59]  C. Benoni,et al.  Effects of smoking on the urine excretion of oral51Cr EDTA in ulcerative colitis , 1998, Gut.

[60]  J. Meddings,et al.  Review article: Intestinal permeability in Crohn's disease , 1997, Alimentary pharmacology & therapeutics.

[61]  G. Verbeke,et al.  Clustering of increased small intestinal permeability in families with Crohn's disease. , 1997, Gastroenterology.

[62]  R. Hilsden,et al.  Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease. , 1996, Gastroenterology.

[63]  J. Gordon,et al.  Inflammatory Bowel Disease and Adenomas in Mice Expressing a Dominant Negative N-Cadherin , 1995, Science.

[64]  C. Benoni,et al.  Does smoking tighten the gut? , 1989, Scandinavian journal of gastroenterology.

[65]  David C. Wilson,et al.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.

[66]  M. Feldman,et al.  Worldwide Human Relationships Inferred from Genome-Wide Patterns of Variation , 2008 .

[67]  T. Kwon,et al.  Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor , 2008, Cell Death and Differentiation.

[68]  J. Beaulieu,et al.  Altered expression of laminins in Crohn's disease small intestinal mucosa. , 2000, The American journal of pathology.

[69]  A. Forbes,et al.  Alterations in classical cadherins associated with progression in ulcerative and Crohn's colitis. , 1998, Laboratory investigation; a journal of technical methods and pathology.